Collaboration brings together clinical stage SHP2 and KRAS G12C inhibitors Relay Therapeutics will receive $75 million upfront and is eligible...
OTTAWA, Dec. 14, 2020 (GLOBE NEWSWIRE) -- HEXO Corp. (“HEXO” or the “Company”) (TSX: HEXO; NYSE:HEXO) is pleased to announce the results of...
REDUCE-IT® EPA Encore Presentation reinforces Eicosapentaenoic Acid (EPA) levels from VASCEPA® (icosapent ethyl) strongly correlated to cardiovascular outcomes, more so...
Analysis of 37 participants immunized with BNT162b2 showed a broad immune response with SARS-CoV-2-specific neutralizing antibodies, TH1 type CD4+ T...
Earlier this fall, the Company announced a joint working agreement to integrate a major manufacturer’s devices with its HealthTab™ data...
Inspired Engineering for Enhanced Visualization MINNEAPOLIS--(BUSINESS WIRE)--#ourpassionyourlife--Smiths Medical, a leading medical device manufacturer, is excited to announce the launch of...
HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI) a biopharmaceutical company focused on novel and targeted oncology therapies, today announced the appointment...
Competitive Strategy Leadership Award Recognizes Avaya’s Extensive Portfolio and Overall Ability to Improve Patient Care and Engagement RALEIGH-DURHAM, N.C.--(BUSINESS WIRE)--Avaya...
IRVINE, Calif.--(BUSINESS WIRE)--Axonics Modulation Technologies, Inc. (Nasdaq: AXNX), a medical technology company that has developed and is commercializing novel implantable...
St. Luke’s University Health Network in Pennsylvania to serve as national model for rapid diagnostic breast cancer centers One-stop breast...
MOUNTAIN VIEW, Calif., Dec. 14, 2020 /PRNewswire/ -- COVID-19 pandemic putting a spotlight on consumers' healthcare behavior, according to a new...
DUBAI, UAE, Dec. 14, 2020 /PRNewswire/ -- "After all these tough months, it was amazing to be part of GITEX and...
- TC-210 induced tumor regression in all of the first eight patients - Ovarian cancer patient achieved confirmed RECIST partial...
JACKSONVILLE, Fla., Dec. 12, 2020 (GLOBE NEWSWIRE) -- The National Lipid Association (NLA) today announced the release of its official...
VASCEPA COVID-19 CardioLink-9 Randomized Trial suggests improvement in patient-reported COVID-19 symptoms while achieving its primary endpoint by demonstrating a 25%...
Demonstrates modularity of Intellia’s in vivo liver insertion technology to durably restore protein, compared to traditional gene therapy Single-course administration...
ANN ARBOR, Mich., Dec. 11, 2020 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), announced...
U.S. FDA authorizes COVID-19 mRNA vaccine for emergency use; companies are prepared to deliver first doses in the U.S. immediatelyPfizer...
CAMPBELL, Calif., Dec. 11, 2020 (GLOBE NEWSWIRE) -- VIVUS, Inc. (the “Company”), a biopharmaceutical company, today announced that it has received...
Primary endpoint achieved with twice-daily dose group at 28 day time point versus latanoprost control group. Patient enrollment and dosing...